Rationale: The function of Nox4, a source of vascular H 2 O 2 , is unknown. Other Nox proteins were identified as mediators of endothelial dysfunction. Objective: We determined the function of Nox4 in situations of increased stress induced by ischemia or angiotensin II with global and tamoxifen-inducible Nox4 ؊/؊ mice. Methods and Results: Nox4 was highly expressed in the endothelium and contributed to H 2 O 2 formation. Nox4 ؊/؊ mice exhibited attenuated angiogenesis (femoral artery ligation) and PEG-catalase treatment in control mice had a similar effect. Tube formation in cultured Nox4 ؊/؊ lung endothelial cells (LECs) was attenuated and restored by low concentrations of H 2 O 2, whereas PEG-catalase attenuated tube formation in control LECs. Angiotensin II infusion was used as a model of oxidative stress. Compared to wild-type, aortas from inducible Nox4-deficient animals had development of increased inflammation, media hypertrophy, and endothelial dysfunction. Mechanistically, loss of Nox4 resulted in reduction of endothelial nitric oxide synthase expression, nitric oxide production, and heme oxygenase-1 (HO-1) expression, which was associated with apoptosis and inflammatory activation. HO-1 expression is controlled by Nrf-2. Accordingly, Nox4-deficient LECs exhibited reduced Nrf-2 protein level and deletion of Nox4 reduced Nrf-2 reporter gene activity. In vivo treatment with hemin, an inducer of HO-1, blocked the vascular hypertrophy induced by Nox4 deletion in the angiotensin II infusion model and carbon monoxide, the product of HO-1, blocked the Nox4-deletion-induced apoptosis in LECs. Conclusion: Endogenous Nox4 protects the vasculature during ischemic or inflammatory stress. Different from Nox1 and Nox2, this particular NADPH oxidase therefore may have a protective vascular function. (Circ Res. 2012;110:1217-1225.)
R eactive oxygen species (ROS) exert a range of different effects in the vascular system. Superoxide anions (O 2 Ϫ ) react with nitric oxide (NO) to form peroxynitrite (ONOO Ϫ ), a process that limits NO availability, results in NO synthase (NOS) uncoupling, and, through the action of ONOO Ϫ , leads to protein and thiol oxidation as well as tyrosine nitration. 1 Hydrogen peroxide (H 2 O 2 ), the dismutation product of O 2 Ϫ , also elicits multiple effects, among them smooth muscle cell hypertrophy, activation of metalloproteinases, and, in higher concentrations, NOS inhibition by phosphorylation of tyrosine 657 through the redox-activated tyrosine kinase Pyk2. 2 Interestingly, H 2 O 2 also induces positive endothelial effects because it can activate protein kinase-G I␣ by thiol oxidation and subsequent dimerization. 3 Moreover, H 2 O 2 induces as well as activates endothelial NOS (eNOS). 4 
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In addition to uncoupled eNOS and mitochondria, the most prominent vascular sources of ROS are NADPH oxidases of the Nox family. 5 In the vascular system Nox1, Nox2, Nox4, and Nox5 are expressed and at least Nox1 and Nox2 have been identified as mediators of endothelial dysfunction. 5, 6 Recently, Nox4 gained considerable attention because it differs from Nox1 and Nox2 in several aspects; Nox4 mRNA expression is higher than that of the other Nox homologues and different from Nox1 and Nox2, which are induced by angiotensin II in vascular smooth muscle cells. 7 Nox4 expression increases in the course of differentiation and is required for the maintenance of a differentiated phenotype in cultured cells. 8 In particular, during the resolution phase after vascular injury, a transient massive upregulation of Nox4 has been observed. 9 Overexpression studies, mostly in HEK293 cells so far, also suggested that Nox4, different from Nox1 and Nox2, is independent of cytosolic activator subunits and thus is potentially constitutively active, suggesting that Nox4dependent ROS production is controlled by the abundance of the enzyme. 10 -12 This aspect does not exclude the possibility that other interacting proteins, such as Poldip2 or protein disulfide isomerase, alter the activity of Nox4. 13 In overexpression systems, Nox4 releases predominately H 2 O 2 , 14 which seems to be a consequence of a particular property of its E-loop. 15 Increased H 2 O 2 formation is also apparent in mice with endothelial-specific Nox4 overexpression. 16 In support of this, Nox4 overexpression in the presence of NO does not lead to ONOO Ϫ formation, 15, 17 and this strongly argues against significant O 2 Ϫ formation by the enzyme. A careful analysis of ROS production of vascular smooth muscle cells also suggested that endogenous Nox4, different from Nox1, produces predominantly H 2 O 2 rather than O 2 Ϫ . 18 It should, however, be mentioned that many other publications linked Nox4 to O 2 Ϫ formation mainly on the basis of an increased fluorescence signaling in the dihydroethidium O 2 Ϫ assay. Nox4 is able to yield an increased fluorescence signal in this assay, but this is not the consequence of an increased formation of the specific O 2 Ϫ adduct, oxyethidium, but rather reflects formation of ethidium by a simple oxidation of the redox probe. 17 In the light of the profoundly different physiological functions of O 2
Ϫ and H 2 O 2 , the endogenous vascular functions of Nox4 are still unknown. Recently, it was demonstrated that endothelial-specific overexpression of the enzyme reduces the blood pressure, improves endothelial function, 16 and increases angiogenesis in the ischemic hind limb of mice. 19 The suitability of overexpression data is, however, limited for the demonstration of the function of the endogenous enzyme and, in that respect, little is known about Nox4. Thus, we generated global and inducible knockout mice and characterized their vascular function in response to two stress models: ischemia and angiotensin II.
Methods
Detailed Methods are provided in the Online Supplement. Tamoxifen-inducible Nox4 Ϫ/Ϫ mice were generated by crossing Nox4 flox/flox with ERT2-Cre 0/ϩ transgenic mice. Mouse lung endothelial cells (LECs) were isolated with magnetic beads. Endothelium-dependent relaxation was studied in preconstricted aortic rings. The mRNA expression was determined by quantitative real-time polymerase chain reaction.
Results

Nox4 Is Highly Expressed in Endothelial Cells
Quantitative real-time-polymerase chain reaction identified high basal Nox4 mRNA expression in human umbilical vein endothelial cells as compared to human aortic smooth muscle cells (Online Figure I) . Similarly, Nox4 mRNA expression was significantly higher in cultured murine LECs than in cultured murine aortic smooth muscle cells. On the protein level, Nox4 expression was readily detectable by Western blot in LEC and the intact mouse aorta and carotid artery, whereas when the endothelium of the arteries was removed by detergent treatment, and not only Nox4 mRNA expression declined but also Nox4 protein decreased substantially (Supplemental Figure I ). Thus, in normal murine arteries, Nox4 expression is higher in endothelial than in smooth muscle cells.
Nox4 Contributes to Basal Vascular H 2 O 2 Formation
To determine whether endogenous Nox4 contributes to basal vascular H 2 O 2 formation, a tamoxifen-inducible Nox4 knockout mouse was generated and a previously characterized global Nox4 knockout mouse was also studied. 20 Nox4 protein was absent in the kidney and lung of global Nox4 Ϫ/Ϫ mice. Tamoxifen treatment of Nox4 flox/flox -ERT2-Cre ϩ/0 mice led to a rapid loss of Nox4 protein ( Figure 1A, B ). Importantly, basal H 2 O 2 levels in LECs harvested from Nox4 Ϫ/Ϫ mice were lower than in wild-type (WT) littermates. Tamoxifen treatment also reduced H 2 O 2 formation in Nox4 flox/flox -ERT2-Cre ϩ/0 LECs but not in WT LECs. Transforming growth factor-␤1, which induces Nox4 in endothelial cells, 21 increased the H 2 O 2 formation in WT cells, and this effect was greatly attenuated in LECs from tamoxifen-treated Nox4 flox/flox -ERT2-Cre ϩ/0 ( Figure 1C ). To determine the contribution of Nox4 to total vascular H 2 O 2 formation, the ferrous oxidation xylenol orange peroxide assay was performed from the intact mouse aorta and demonstrated that Nox4 accounts for approximately 75% of the vascular H 2 O 2 formation ( Figure 1D ). Thus, endogenous Nox4 is a constitutively active and inducible source of H 2 O 2 in endothelial cells and the mouse aorta.
Nox4-Derived Endogenous H 2 O 2 Promotes Angiogenic Responses
To determine the role of Nox4 in response to ischemia, we subjected knockout mice to femoral artery ligation. Blood flow recovery was significantly attenuated in global Nox4 Ϫ/Ϫ mice as well as in inducible Nox4 Ϫ/Ϫ mice as compared to WT littermates. This effect was not observed with genetic deletion of Nox1 or Nox2 and the blood flow recovery of Nox1 y/Ϫ mice was even faster than that of WT littermates To address whether Nox4-derived H 2 O 2 is involved in angiogenic responses of endothelial cells, we performed matrigel tube formation assays. LEC is from Nox4 Ϫ/Ϫ mice generated 50% less branching points than WT cells. Low 
Figure 2. Endogenous Nox4 and H 2 O 2 are required for blood flow recovery after femoral artery ligation (A) and endothelial tube formation (B). A, Laser
Doppler images and statistics for days 7 and 14 of the blood flow ratio of the ischemic (R) and the control (L) leg in litter mates. For Nox4, global (Nox4 Ϫ/Ϫ ) as well as inducible knockouts were studied. Nox4 flox/flox -ERT2-Cre ϩ/0 (Cre flox) and Nox4 flox/flox -ERT2-Cre 0/0 litter mates (CTL flox) were both pretreated with tamoxifen before operation. Nox4ϩPEG catalase denotes an experiment in which both groups received intravenous injections of PEG catalase (100,000 U/kg) before and 1 day after surgery. ϮPEG-catalase denotes C57BL6/J mice treated with PEG catalase (ϩPEG catalase) or solvent (wild-type [WT]) *PϽ0.05. For technical reasons, the laser Doppler measurements on the Nox2 strain were only performed 2 weeks after the operation. B, Matrigel tube formation assay in lung endothelial cells from Nox4 ϩ/ϩ (WT) and Nox4 Ϫ/Ϫ mice in the presence or absence of H 2 O 2 and PEG catalase (100 U/mL). nϭ6 to 7. # PϽ0.05 WT vs Nox4. *PϽ0.05 with vs without H 2 O 2 or PEG catalase.
concentrations of H 2 O 2 (1 and 3 mol/L) had no effect on WT LECs but normalized branching in Nox4 Ϫ/Ϫ cells. High concentrations of H 2 O 2 (30 mol/L) blocked tube formation in both groups (Figure 2 bottom). In keeping with the observation that low concentrations of H 2 O 2 are required for a normal response in this assay, PEG-catalase significantly inhibited basal tube formation in WT LECs with little effect on Nox4-deficient endothelial cells. To determine whether in vivo H 2 O 2 also is required for angiogenic responses, PEGcatalase was injected on the day of and 1 day after femoral artery ligation in WT mice. In vivo PEG-catalase significantly attenuated the blood flow recovery in this model ( Figure 2 ). Thus, angiogenic responses require low concentrations of Nox4-derived H 2 O 2 .
Endogenous Nox4 Does Not Affect Angiotensin II-Induced Hypertension
Angiotensin II-induced hypertension is the prototypic situation of increased vascular oxidative stress. We therefore determined the impact of genetic deletion of Nox4 in this situation. Angiotensin II was applied at a low pressor dose (0.7 mg/kg/d). Lack of Nox4 had no effect on basal blood pressure or the angiotensin II-induced hypertensive response, as measured by telemetry in inducible knockout mice or by the tail-cuff technique in global Nox4 Ϫ/Ϫ animals (Supplemental Figure III ).
Lack of Nox4 Potentiates the Vascular Effects of Angiotensin II
Because blood pressure is a complex read-out, we also determined vascular nitric oxide availability by bioassay experiments in aortic segments of mice treated with a high proinflammatory concentration of angiotensin II (2.2 mg/kg/ d). The acetylcholine-induced endothelium-dependent vasodilation of isolated aortic segments under basal conditions was similar between WT and global as well as inducible Nox4 Ϫ/Ϫ mice. After in vivo angiotensin II treatment, however, acetylcholine relaxations were impaired in the aorta of Nox4-deficient mice as compared to the aorta of the control animals ( Figure 3A , B and Supplemental Figure IVA, B) . As a second measure for NO availability, we determined the nitro-L-arginine-induced endothelium-dependent constrictor response in phenylephrine-preconstricted aortic segments, which after angiotensin II treatment was also impaired in Nox4-deficient vascular segments ( Figure 3C , Supplemental Figure IV ). As these data suggest that deficiency of Nox4 may potentiate angiotensin II-induced vascular dysfunction, the effect of acute genetic deletion of Nox4 on the angiotensin II-induced hypertrophic and proinflammatory aortic response was determined. Deletion of Nox4 increased aortic expression of inflammatory cytokines and aortic media hypertrophy in response to angiotensin II ( Figure 3D -G, Supplemental Figure V) . In contrast, ge- 
Nox4 Maintains the Activity of Protective Endothelial Mediators
To determine whether the negative effects of Nox4 deletion are a consequence of dysregulation of other Nox homologues or of antioxidant enzymes, quantitative real-time polymerase chain reaction experiments were performed in murine tissue. Deletion of Nox4, however, had no significant effect on the expression of SOD1, SOD2, SOD3, or catalase, or on vascular expression of Nox1 and Nox2 (Supplemental Figure  VI) . As a possible alternative, Nox4 could control the production of protective endothelial mediators like NO or carbon monoxide (CO). Acute deletion of Nox4 led to a 50% reduction in NO formation by LEC as measured by DAF-2 ( Figure 4A) . Similarly, plasma nitrite levels 2 weeks after femoral artery ligation were significantly lower in Nox4* / * as compared with control mice ( Figure 4B ). This effect potentially could be a consequence of a loss of eNOS expression after Nox4 deletion; quantitative real-time-polymerase chain reaction and Western blot from the mouse carotid artery demonstrated that deletion of Nox4 reduced eNOS expression by approximately 50% (Figure 4C, D) . Also, heme oxygenase (HO), the enzymatic source of antiinflammatory CO, was modulated by Nox4. Whereas HO-2 is constitutively expressed in endothelial cells, HO-1 expression is redox-sensitive. 22 Nox4 deletion reduced HO-1 but not HO-2 expression of LEC, which was paralleled by an increase in endothelial cell apoptosis as well as endothelial E-selectin expression, a sensitive marker of endothelial activation (Figure 5A, B) .
Endogenous Nox4 Controls Basal Endothelial Nrf-2 Activity
HO-1 expression is, among others, controlled by the redoxsensitive transcription factor Nrf-2, which is stabilized in response to oxidative and electrophilic stress. 23 Thus, we hypothesized that endogenous H 2 O 2, derived from vascular Nox4, controls Nrf-2. Western blots and reporter gene assays were performed to assess the impact of Nox4 on Nrf-2 in LECs. Before tamoxifen treatment, basal Nrf-2 reporter activity was identical between Nox4 flox/flox -ERT2-Cre ϩ/0 and WT cells. Tamoxifen, probably by a direct antioxidant effect, somewhat decreased the Nrf-2 reporter gene activity in WT cells, whereas tamoxifen-driven deletion of Nox4 resulted in a substantial reduction. After tamoxifen treatment, the Nrf-2 reporter gene activity was significantly lower in Nox4deficient cells as compared with control cells, suggesting that Nox4 may support Keap oxidation and thus prevents Nrf2 degradation ( Figure 5C ). Accordingly, Nrf-2 protein expression was significantly lower in Nox4-deficient as compared with WT LECs (Figure 5A) , which corresponded to an attenuated vascular expression of HO-1 ( Figure 6A ).
Increasing the HO-1-CO System Can Compensate the Lack of Nox4
To assay whether Nrf-2-driven HO-1 expression contributes to the protective effects of Nox4 in vivo, we treated mice with the HO-1 inducer hemin. Hemin not only increased aortic HO-1 expression ( Figure 6A ) but also prevented the detrimental effect of Nox4 deletion on angiotensin II-induced vascular hypertrophy ( Figure 6B ). To determine whether CO, a HO-1 product, could mediate this effect, we focused on endothelial cell apoptosis. Two chemically distinct COreleasing molecules (CORMs; CORM-A1 and CORM2), but not decomposed CORMs, prevented apoptosis induced by acute deletion of Nox4 in LEC ( Figure 6C, D) . Thus, downregulation of the Nrf2-HO-1-CO system may contribute to the effects occurring in response to the genetic deletion of Nox4.
Discussion
This study provides evidence that endogenous Nox4 acts as a vasoprotective protein through mechanisms that include H 2 O 2 generation, maintenance of NO production, and antioxidant HO-1 expression. Genetic deletion of Nox4 therefore attenuated ischemia-induced angiogenesis and potentiated responses to angiotensin II.
These observations suggest that endogenous vascular Nox4 may protect vascular function, which is unexpected given the present knowledge of Nox proteins. Numerous studies demonstrated that other Nox proteins, although important for physiological signaling under normal conditions, are mediators of vascular dysfunction, particularly in angiotensin IIinduced stress situations. 5 Thus, Nox4 might have an antagonistic function to Nox1 and Nox2 and thus differs from these NADPH oxidases. Nox4 is a special Nox because it has a high constitutive activity and is highly expressed in some cells. Moreover, different from Nox1 and Nox2, Nox4 releases predominantly H 2 O 2 , 18 which cannot scavenge NO. 15, 17 Indeed, targeting SOD to the endothelium attenuated angiotensin II-induced vascular dysfunction, whereas catalase was without effect. 24 Thus, the concept of eNOS uncoupling, an important mechanism underlying vascular dysfunction, which has been well-established for the O 2
Ϫ sources Nox1 and Nox2, 25 may not apply to Nox4. Moreover, it is progressively becoming clear that low concentrations of H 2 O 2 elicit positive effects in the vascular system; H 2 O 2 not only is a vasodilator by activating protein kinase-G I␣ 3 but also it may activate and induce eNOS by several mechanisms. 4 Indeed, our data suggest that endogenous Nox4 enhances vascular eNOS expression and NO formation.
A second relevant effect of Nox4, which could be mediated by H 2 O 2 , is the maintenance of HO-1 expression. Although HO-1 confers vascular protection by several mechanisms, 26 we focused on its product CO. Endothelial cell apoptosis is an important stimulus for vascular inflammation. 27 Deletion of Nox4 increased the apoptosis rate of endothelial cells and, importantly, two chemical-distinct CORMs prevented this effect. Moreover, in vivo treatment with hemin, an inducer of HO-1, attenuated the Nox4 deletion-induced potentiation of the hypertrophic effect of angiotensin II. Hemin could have other off-target effects, but the similar responses observed with CORMs suggest that at least part of its action may be CO-related.
HO-1 expression is controlled by the transcription factor Nrf-2, which accumulates in cells after H 2 O 2 -mediated oxidation of its inhibitor Keap. In the absence of H 2 O 2 or other electrophiles, Keap facilitates the degradation of Nrf-2. In line with our observation that basal Nox4 controls Nrf-2, it was observed that myocardial overexpression of Nox4 also increases the level of this transcription factor. 28 Despite all these possible positive vascular effects, it also should be mentioned that H 2 O 2 is a proliferative stimulus for vascular smooth muscle cells and numerous studies have demonstrated that catalase attenuates the hypertrophic effect of angiotensin II and even linked hypertrophy to NADPH oxidase activation. 29 Thus, how could Nox4-derived H 2 O 2 limit angiotensin II-induced vascular hypertrophy and inflammation? A potential explanation could be that endothelial expression of Nox4 in the vessel is much higher than in the smooth muscle layer. In fact, although it has been demonstrated in cultured smooth muscle cells that Nox4 fulfills many functions in this cell type, 6 until now a careful comparison between endothelial and smooth muscle cell Nox4 expression was not performed. Our data show that in normal vessels Nox4 expression predominates in endothelial cells and is lower in the smooth muscle layer of the vessel. Accordingly, it was previously noted that in the rat carotid artery, smooth muscle Nox4 expression largely increases in the resolution phase after injury and decreases under normal conditions. 9 Figure 5 . Nox4 maintains endothelial quiescence and Nrf2 activity. Lung endothelial cells (LECs) from Nox4 flox/flox -ERT2-CRE ϩ/0 (Nox4* / *) and Nox4 flox/flox -ERT2-Cre 0/0 littermates (wild-type [WT]) were studied. A, Western blot analysis for the proteins indicated in LEC 3 days after hydroxytamoxifen treatment. HO-1, heme oxygenase-1; HO-2, heme oxygenase-2. Beta-actin and ERK1/2 were used as loading controls. Numbers below the blots show the result of the relative densitometry. B, Annexin V assay for apoptosis in LECs on days 2 and 3 of hydroxy-tamoxifen incubation (nՆ3; *PϽ0.05 WT vs Nox4*/*). C, Nrf-2 luciferase reporter gene activity relative to the pGL3P control plasmid in transiently transfected LECs studied in the presence or absence of hydroxytamoxifen (OH-TMX; 10 mol/L).
Why should a preferential endothelial versus smooth muscle expression of Nox4 be important? Although not extensively studied, H 2 O 2 in the two layers may have different functions as demonstrated by several studies on endothelial and smooth muscle-specific local increases in catalase activity: For example, smooth muscle-specific catalase overexpression blocks the H 2 O 2 -mediated angiotensin II-induced vascular hypertrophy, 30 whereas endothelial-specific catalase overexpression prevents exercise-stimulated induction of eNOS. 31 Given the role of H 2 O 2 for eNOS expression, the protective effect of endogenous Nox4 in angiogenesis appears conclusive. Overexpression of Nox4 increases angiogenesis by a pathway involving NO. 19 Conversely, PEG-catalase was as effective as knockdown of Nox4 to limit ischemia-induced angiogenesis, and these data are in keeping with a recent communication that endothelial-specific catalase overexpression attenuates angiogenesis in the femoral artery ligation model. 32 The role of Nox1 and Nox2 in angiogenesis is controversial. Nox1 is involved in tumor angiogenesis, 33 whereas in the present study it rather inhibited ischemiainduced angiogenesis. Nox2 is required for vascular endothelial growth factor signaling 34 and, in line with this, attenuated angiogenesis in Nox2-deficient mice was demonstrated. 35 Several more recent studies, similar to the present work, however found no evidence for attenuated angiogenic responses in Nox2-deficient mice. 33, 36 The basis of these discrepant results is currently unclear.
Our present study on a protective function of endogenous Nox4 contrasts with many observations suggesting a deleterious function of Nox4 that link the enzyme to senescence, inflammatory signaling, fibrosis, and even apoptosis. 6 Many of these studies were performed on cultured cells or cell lines and on the basis of siRNA technology. Not only do cultured cells respond more vigorously to changes than whole organisms but also responses are often complex. For example, as expression of Nox1, Nox2, and p47phox is redox-stimulated, downregulation of Nox4 by siRNA frequently also downregulates these proteins (K. Schröder, unpublished observation, 2009), whereas this was not the case in the present study. Also, the differentiation state of the cells is of critical importance; whereas transforming growth factor ␤-1 induces differentiation in endothelial cells, it results in apoptosis of epithelial cells and, interestingly, excessive induction of Nox4 and massive subsequent oxidative stress appears to be involved in this process. 37 The level of Nox4 and subsequently produced H 2 O 2 might be decisive for the effects observed. In the vascular system, too high concentrations of H 2 O 2 are deleterious and this effect also was observed in the present study in the U-shape response of Nox4-deficient endothelial cells to H 2 O 2 in the tube formation assay. These considerations may reconcile the suggested negative role of vascular Nox4 in diabetes or pulmonary hypertension, although these situations have not yet been studied in Nox4 knockout mice.
Despite the protective effect on endothelial function in isolated aortic rings, deletion of Nox4 did not alter the hypertensive response to angiotensin II in vivo or the basal blood pressure. These findings can be interpreted in multiple ways. Because the aorta does not contribute to peripheral resistance, it is not known whether our current findings extend into the resistance vessels, where additional vasodilators become important and the ratio of endothelium to smooth muscle is more favorable. It may also support the notion that endothelial dysfunction does not necessarily lead to hypertension. Hypertension is the consequence of a complex dysregulation of many systems not only involving vessels but also involving the heart as well as renal and cerebral regulation loops.
Obviously, the concept of endothelial cells continuously generating significant amounts of ROS (even if it is "only" H 2 O 2 ) is somewhat counter to the traditional concept of these species as a driving force for disease development. The latter paradigm, however, has been questioned more and more. The cellular redox milieu is rigorously controlled by specialized redox sensors such as the Nrf-2/ Keap system, and a notion prevails that the traditional toxic ROS, like hydroxyl radicals, Figure 6 . Activation of the heme oxygenase-1 (HO-1)-carbon monoxide (CO) system prevents effects induced by Nox4 deletion. A and B, Aortic HO-1 expression and weight. Nox4 flox/flox -ERT2-Cre 0/0 (wild-type [WT]) and Nox4 flox/flox -ERT2-Cre 0/ϩ (Nox4* / *) were injected with tamoxifen for 3 consecutive days and subsequently infused with angiotensin II (AngII) for 2 weeks (2.2 mg/kg/d). To induce HO-1, hemin (intraperitoneal 25 mg/kg every third day) was administered in subgroups. A, Vascular HO-1 expression as determined by quantitative real-time polymerase chain reaction in aortic segments (nϭ5; *PϽ0.05 with vs without hemin). B, Normalized thoracic aortic weight (nϭ5; *PϽ0.05 WT vs Nox4* / *; #PϽ0.05 with vs without hemin). C and D, Annexin V assay for apoptosis in murine lung endothelial cells. Cells of Nox4 flox/flox -ERT2-Cre 0/0 (WT) and Nox4 flox/flox -ERT2-Cre 0/ϩ mice (Nox4* / *) were treated with or without hydroxytamoxifen (10 mol/L) in the presence of (C) CO-releasing molecule (CORM) A1 (200 mol/L, solved in medium, fresh daily) or (D) CORM2 (200 mol/L, dissolved in DMSO to 1.5 mol/L and then further in medium to 200 mol/L, fresh daily) or solvent for 3 days. Solvent controls for the CORMs were prepared by dissolving CORMs as described and by incubating them for 24 hours at room temperature under exposure to light. After that, the solution was vigorously vortexed to remove residual carbon monoxide. nϭ7; *PϽ0.05 Nox4* / * solvent vs Nox4* / * with CORM.
are not subject to regulation in the body simply because of their high reaction speed. 38 Thus, signaling ROS such as H 2 O 2 may have a very different impact on cellular function in particular because the system is much more compartmentalized than initially thought. 39, 40 From a holistic point of view, a beneficial Nox4 therefore makes a lot of sense. A continuous production of H 2 O 2 maintains a basal level of antioxidant defense and this would desensitize or protect cells against an acute oxidative challenge. Future studies on Nox4 knockout mice therefore will have to prove whether this system is specific for the vasculature or of more general importance. Obviously, expression control of Nox4 will become very important in this aspect. Only moderate levels of the enzyme but not excessive induction will yield the beneficial function. Thus, depending on the disease models used, Nox4 may be protective or harmful. For the vascular system in the settings investigated in this study, however, our data suggest that Nox4 is a beneficial source of ROS.
In conclusion, the present study identifies endogenous Nox4 as a constitutive endothelial generator of H 2 O 2 that positively affects vascular function. Low tonic production of H 2 O 2 is vasoprotective and this could, at least in part, explain the failure of antioxidant therapy to prevent vascular disease in clinical trials. Although endogenous Nox4 appears to have a minor impact on function in healthy vessels, it controls eNOS and HO-1 expression. Thus, in disease situations such as ischemia-induced angiogenesis and angiotensin II-induced vascular dysfunction, a lack of Nox4 potentiates the disease phenotype. Nox4 therefore is a protective NADPH oxidase and may antagonize the action of Nox1 and Nox2. Nox4 inhibitors, which are currently being developed for clinical use, therefore should be carefully monitored for negative vascular side effects.
